• 검색 결과가 없습니다.

Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic TherapiesOncology & Hematology

N/A
N/A
Protected

Academic year: 2021

Share "Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic TherapiesOncology & Hematology"

Copied!
16
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Fig. 1. Overview of epigenetic mechanisms and targeting agents.
Table 2. Selected epigenetic target agents in combination therapy clinical trials

참조

관련 문서

Serum uric acid levels and risk for vascular disease in patients with metabolic syndrome... Prevalence if the metabolic syndrome in a Turkish

 The final results of risk calculation and presentation are individual risk measures, societal risk F-N plots or

흉부 진찰 및 복부 진 찰에서는 특이 소견이 없었고, 만져지는 림프절도 없었다.. 피부에도 특 별한

3. Not meeting WHO criteria for BCR-ABL1 + CML, PV, PMF, myelodysplastic syndromes, or other myeloid neoplasms 4. Presence of JAK2, MPL, or CALR,

• Despite medical intervention with supportive care (78% of the patients use corticosteroids), patients continued to show disabling symptoms, progressive complications,

(2003), Nosocomial Infection of Malnourished Patients in an Intensive Care Unit. Anal ysis of Nutritional Support Status in the Intensive Care Unit. Korean J crit Ca re Med.

In addition, if the patients had a high MPV level (cut-off value of 7.95 fL) without low-dose aspirin therapy, they were at risk for ischemic stroke, especially in

Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a